Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2011 May 10;254(3):280–287. doi: 10.1016/j.taap.2011.05.002

Figure 4.

Figure 4

Effect of PAHs on deformities and EROD induction in non-injected (NI) and AHR2-morpholino-injected (AHR2-mo) embryos. Embryos were dosed at 24 hpf and scored at 96 hpf. Deformities are represented by bars, and scale is along the left y-axis; values are expressed as percent NI control (DMSO) pericardial effusion ± SEM (n = 12 per treatment; each n represents average of five embryos). EROD values are represented by lines and scale is along the right y-axis; values are expressed as percent NI control EROD ± SEM (n = 9 per treatment). For EROD comparisons, groups not sharing a common letter are significantly different (p ≤0.05; ANOVA, Tukey adjusted LSMeans). For deformity comparisons, an asterisk (*) represents a significant difference from control (p ≤0.05; ANOVA, Tukey adjusted LSMeans).